(Q37962676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Post-kala-azar dermal leishmaniasis: recent developments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

visceral leishmaniasis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Umakant Sharma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jyotsna Mishra

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Dermatology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1099-1108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126871%20AND%20SRC:MED&resulttype=core&format=json

Indian kala-azar caused by Leishmania tropica

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Post-kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Post-kala-azar dermal leishmaniasis associated with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Molecular epidemiology and population genetics in Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Nodular post-kala-azar dermal leishmaniasis: a distinct histopathological entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Applications of molecular methods for Leishmania control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Molecular diagnosis of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Direct identification of Leishmania species in biopsies from patients with American tegumentary leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Nerve Involvement in Indian Post Kala-Azar Dermal Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X

Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.04925.X